Adapter proteins in lymphocyte antigen-receptor signaling

Current Opinion in Immunology

Volumn 12, Issue 3, 2000, Pages 256-266

  Myung, Peggy S ^a   Boerthe, Nancy J ^a   Koretzky, Gary A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; T LYMPHOCYTE RECEPTOR;

LYMPHOCYTE FUNCTION; MOLECULAR INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034008281     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00085-6     Document Type: Review

References (96)

1. June C.H., Fletcher M.C., Ledbetter J.A., Samelson L.E. Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation. J Immunol. 144:1990;1591-1599.
2. Straus D.B., Weiss A. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell. 70:1992;585-593.
3. Kurosaki T., Takata M., Yamanashi Y., Inazu T., Taniguchi T., Yamamoto T., Yamamura H. Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. J Exp Med. 179:1994;1725-1729.
4. Weiss A., Koretzky G., Schatzman R.C., Kadlecek T. Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase C-gamma 1. Proc Natl Acad Sci USA. 88:1991;5484-5488.
5. Karnitz L., Sutor S.L., Torigoe T., Reed J.C., Bell M.P., McKean D.J., Leibson P.J., Abraham R.T. Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line. Mol Cell Biol. 12:1992;4521-4530.
6. Hempel W.M., Schatzman R.C., DeFranco A.L. Tyrosine phosphorylation of phospholipase C-gamma 2 upon cross-linking of membrane Ig on murine B lymphocytes. J Immunol. 148:1992;3021-3027.
7. von Willebrand M., Baier G., Couture C., Burn P., Mustelin T. Activation of phosphatidylinositol-3-kinase in Jurkat T cells depends on the presence of the p56lck tyrosine kinase. Eur J Immunol. 24:1994;234-238.
8. Williams B.L., Schreiber K.L., Zhang W., Wange R.L., Samelson L.E., Leibson P.J., Abraham R.T. Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor. reconstitution studies in a ZAP-70-deficient Jurkat T-cell line Mol Cell Biol. 18:1998;1388-1399.
9. Pawson T., Scott J.D. Signaling through scaffold, anchoring, and adaptor proteins. Science. 278:1997;2075-2080.
10. Wange R.L., Samelson L.E. Complex complexes. signaling at the TCR Immunity. 5:1996;197-205.
11. Peterson E.J., Clements J.L., Fang N., Koretzky G.A. Adaptor proteins in lymphocyte antigen-receptor signaling. Curr Opin Immunol. 10:1998;337-344.
12. Schlessinger J. SH2/SH3 signaling proteins. Curr Opin Genet Dev. 4:1994;25-30.
13. Kavanaugh W.M., Turck C.W., Williams L.T. PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science. 268:1995;1177-1179.
14. Sudol M., Chen H.I., Bougeret C., Einbond A., Bork P. Characterization of a novel protein-binding module - the WW domain. FEBS Lett. 369:1995;67-71.
15. Harlan J.E., Hajduk P.J., Yoon H.S., Fesik S.W. Pleckstrin homology domains bind to phosphatidylinositol-4,5- bisphosphate. Nature. 371:1994;168-170.
16. Zhang W., Sloan-Lancaster J., Kitchen J., Trible R.P., Samelson L.E. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell. 92:1998;83-92. This study describes the cloning and characterization of LAT isolated from Jurkat T cells. The authors show that LAT is tyrosine phosphorylated by ZAP-70 and Syk PTKs, resulting in its phosphotyrosine-dependent association with Grb2, PI3K and PLCγ1 in Jurkat T cells. In addition, overexpression of a LAT mutant that cannot be phosphorylated on residues Tyr171 and Tyr191 results in a dominant inhibition of TCR-induced NF-AT and AP-1 transcriptional activities.
17. Zhang W., Trible R.P., Samelson L.E. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity. 9:1998;239-246. This structure/function analysis of LAT focuses on residues required for its palmitoylation and subsequent targeting to GEMs in Jurkat T cells. This study first demonstrated the importance of localizing LAT not only to the plasma membrane but also to discrete domains within the membrane in order for it to efficiently couple to upstream and downstream signaling pathways. The authors find that palmitoylation of LAT is required for its tyrosine phosphorylation following TCR ligation.
18. •].
19. •].
20. •] describe the identification and characterization of Gads/Grf40/GrpL as a hematopoietic-specific Grb2 homologue that associates with SLP-76 and LAT in Jurkat T cells. The authors demonstrate that Gads functions in concert with SLP-76 to augment IL-2 NF-AT promoter activity following TCR ligation and that mutation of its SH2 domain results in dominant inhibition of this activity.
21. ••].
22. ••]. The authors describe the phenotype of Jurkat T cell lines deficient in LAT expression and show a requirement for LAT in mediating TCR-induced PLCγ1 phosphorylation, calcium influx, ERK activation and IL-2 promoter activity while maintaining intact upstream biochemical events such as ZAP-70 phosphorylation. In addition, the essential role of LAT palmitoylation in mediating TCR-induced signaling events is illustrated by studies in which expression of a LAT mutant that cannot be palmitoylated in LAT-deficient cells fails to reconstitute TCR signals.
23. -) stage, which requires signals mediated through a pre-TCR.
24. Lin J., Weiss A., Finco T.S. Localization of LAT in glycolipid-enriched microdomains is required for T cell activation. J Biol Chem. 274:1999;28861-28864.
25. Jackman J.K., Motto D.G., Sun Q., Tanemoto M., Turck C.W., Peltz G.A., Koretzky G.A., Findell P.R. Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells. J Biol Chem. 270:1995;7029-7032.
26. Clements J.L., Ross-Barta S.E., Tygrett L.T., Waldschmidt T.J., Koretzky G.A. SLP-76 expression is restricted to hemopoietic cells of monocyte, granulocyte, and T lymphocyte lineage and is regulated during T cell maturation and activation. J Immunol. 161:1998;3880-3889.
27. Musci M.A., Hendricks-Taylor L.R., Motto D.G., Paskind M., Kamens J., Turck C.W., Koretzky G.A. Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases. J Biol Chem. 272:1997;11674-11677.
28. da Silva A.J., Li Z., de Vera C., Canto E., Findell P., Rudd C.E. Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production. Proc Natl Acad Sci USA. 94:1997;7493-7498.
29. Wardenburg J.B., Fu C., Jackman J.K., Flotow H., Wilkinson S.E., Williams D.H., Johnson R., Kong G., Chan A.C., Findell P.R. Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function. J Biol Chem. 271:1996;19641-19644.
30. Fang N., Koretzky G.A. SLP-76 and Vav function in separate, but overlapping pathways to augment interleukin-2 promoter activity. J Biol Chem. 274:1999;16206-16212.
31. Raab M., da Silva A.J., Findell P.R., Rudd C.E. Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of interleukin-2. Immunity. 6:1997;155-164.
32. Bubeck-Wardenburg J., Pappu R., Bu J.Y., Mayer B., Chernoff J., Straus D., Chan A.C. Regulation of PAK activation and the T cell cytoskeleton by the linker protein SLP-76. Immunity. 9:1998;607-616.
33. Su Y.W., Zhang Y., Schweikert J., Koretzky G.A., Reth M., Wienands J. Interaction of SLP adaptors with the SH2 domain of tec family kinases. Eur J Immunol. 29:1999;3702-3711. This study provided the first evidence of a direct association between SLP-76 and Itk and, thus, a possible mechanism for the ability of SLP-76 to regulate PLCγ1 in T cells. Su et al. show that the SH2 domains of Btk and Itk directly bind to SLP-65 and SLP-76, respectively, following antigen-receptor stimulation. The authors use both in vitro methods and studies from intact cells to demonstrate these associations, providing a possible mechanism for the regulation of PLCγ through the association between SLP adapters and tec-family kinases.
34. Motto D.G., Ross S.E., Wu J., Hendricks-Taylor L.R., Koretzky G.A. Implication of the GRB2-associated phosphoprotein SLP-76 in T cell receptor-mediated interleukin 2 production. J Exp Med. 183:1996;1937-1943.
35. Yablonski D., Kuhne M.R., Kadlecek T., Weiss A. Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell. Science. 281:1998;413-416. This study utilizes a SLP-76-deficient Jurkat T cell line to illustrate the essential role SLP-76 plays in mediating TCR-dependent signaling events, including PLCγ1 phosphorylation, calcium mobilization, ERK activation and the stimulation of NF-AT and AP-1 transcriptional activities. However, SLP-76 is not required for early biochemical events such as ZAP-70 and LAT phosphorylation.
36. ••].
37. - stage, indicative of a signaling defect through the pre-TCR.
38. Musci M.A., Motto D.G., Ross S.E., Fang N., Koretzky G.A. Three domains of SLP-76 are required for its optimal function in a T cell line. J Immunol. 159:1997;1639-1647.
39. Fang N., Motto D.G., Ross S.E., Koretzky G.A. Tyrosines 113, 128, and 145 of SLP-76 are required for optimal augmentation of NFAT promoter activity. J Immunol. 157:1996;3769-3773.
40. Geng L., Raab M., Rudd C.E. Cutting edge: SLP-76 cooperativity with FYB/FYN-T in the up-regulation of TCR-driven IL-2 transcription requires SLP-76 binding to FYB at Tyr595 and Tyr651. J Immunol. 163:1999;5753-5757.
41. Raab M., Kang H., da Silva A., Zhu X., Rudd C.E. FYN-T-FYB-SLP-76 interactions define a T-cell receptor zeta/CD3-mediated tyrosine phosphorylation pathway that up-regulates interleukin 2 transcription in T-cells. J Biol Chem. 274:1999;21170-21179.
42. Veale M., Raab M., Li Z., da Silva A.J., Kraeft S.K., Weremowicz S., Morton C.C., Rudd C.E. Novel isoform of lymphoid adaptor FYN-T-binding protein (FYB-130) interacts with SLP-76 and up-regulates interleukin 2 production. J Biol Chem. 274:1999;28427-28435.
43. Yablonski D., Kane L.P., Qian D., Weiss A. A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK. EMBO J. 17:1998;5647-5657.
44. Liu K.Q., Bunnell S.C., Gurniak C.B., Berg L.J. T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J Exp Med. 187:1998;1721-1727.
45. Shan X., Wange R.L. Itk/Emt/Tsk activation in response to CD3 cross-linking in Jurkat T cells requires ZAP-70 and Lat and is independent of membrane recruitment. J Biol Chem. 274:1999;29323-29330.
46. Sanzenbacher R., Kabelitz D., Janssen O. SLP-76 binding to p56lck: a role for SLP-76 in CD4-induced desensitization of the TCR/CD3 signaling complex. J Immunol. 163:1999;3143-3152.
47. Fu C., Chan A.C. Identification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase C gamma, Grb2, and Vav after B cell antigen receptor activation. J Biol Chem. 272:1997;27362-27368.
48. •].
49. •] describe the cloning and initial characterization of SLP-65/BLNK/BASH in B cells. Fu et al. isolated SLP-65 from BCR-activated human Ramos B cells based on its ability to bind PLCγ1, whereas Goitsuka et al. utilized PCR-based subtraction and differential hybridization to isolate a cDNA preferentially expressed in chicken B cells of the bursa of Fabricius. Both groups show that SLP-65 is tyrosine phosphorylated by Syk upon BCR stimulation. Fu et al. show that SLP-65 associates with PLCγ, Vav, Grb2 and Nck, but not Shc, in a B cell line. However, Goitsuka et al. find an association between SLP-65 and Shc. Fu et al. also show that overexpression of SLP-65 in B cells augments BCR-induced PLCγ1/γ2 phosphorylation and NF-AT activation, and that mutation of four of its tyrosine residues results in decreased NF-AT activation compared with parental cells. In contrast, Goitsuka et al. find that overexpression of SLP-65 interferes with BCR-induced NF-AT activation.
50. Hashimoto S., Iwamatsu A., Ishiai M., Okawa K., Yamadori T., Matsushita M., Baba Y., Kishimoto T., Kurosaki T., Tsukada S. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK - functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signalling. Blood. 94:1999;2357-2364.
51. 3 generation. These defects can be overcome by transfection of either wild-type BLNK or a membrane-bound form of PLCγ2. In addition BCR-stimulated JNK and p38 activation were abrogated in this mutant cell line and could not be restored by expression of a membrane-bound form of PLCγ2, suggesting that BLNK is also involved in the Rac1/JNK pathway.
52. ••].
53. ••] provide in vivo evidence that supports a required role for SLP-65 in B cell development at the pro-B cell to pre-B cell transition, indicating an important function for SLP-65 in pre-BCR signaling. Additionally, impaired signaling through the IgM BCR is also suggested in these studies.
54. Khan W.N., Alt F.W., Gerstein R.M., Malynn B.A., Larsson I., Rathbun G., Davidson L., Muller S., Kantor A.B., Herzenberg L.A. Defective B cell development and function in Btk-deficient mice. Immunity. 3:1995;283-299.
55. Minegishi Y., Rohrer J., Coustan-Smith E., Lederman H.M., Pappu R., Campana D., Chan A.C., Conley M.E. An essential role for BLNK in human B cell development. Science. 286:1999;1954-1957. The critical function of SLP-65 in B cell development is further demonstrated by this study in which an absence of B cells and early onset agammaglobulinemia was identified in a human patient found to lack SLP-65 expression. This study characterizes the splice defect found in the SLP-65 alleles of this patient and correlates it with a complete block in B cell development at the pro-B cell to pre-B cell transition.
56. Tsukada S., Rawlings D.J., Witte O.N. Role of Bruton's tyrosine kinase in immunodeficiency. Curr Opin Immunol. 6:1994;623-630.
57. Tsukada S., Saffran D.C., Rawlings D.J., Parolini O., Allen R.C., Klisak I., Sparkes R.S., Kubagawa H., Mohandas T., Quan S. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X- linked agammaglobulinemia. Cell. 72:1993;279-290.
58. Vetrie D., Vorechovsky I., Sideras P., Holland J., Davies A., Flinter F., Hammarstrom L., Kinnon C., Levinsky R., Bobrow M. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 361:1993;226-233.
59. Cao M.Y., Davidson D., Yu J., Latour S., Veillette A. Clnk, a novel SLP 76-related adaptor molecule expressed in cytokine-stimulated hemopoietic cells. J Exp Med. 190:1999;1527-1534. This study describes the cloning of CLnk by use of a yeast two-hybrid approach. Characterization of this novel adapter reveals that CLnk is selectively expressed in cytokine-stimulated hemopoietic cells, including IL-2-treated T cell lines and NK cells, IL-3-dependent myeloid cells and bone-marrow-derived mast cells grown in IL-3. CLnk becomes tyrosine phosphorylated and associates with an unidentified 92 kDa phosphoprotein upon TCR stimulation of an IL-2-treated T cell line. In addition overexpression of CLnk in Jurkat T cells augments TCR-induced NF-AT, AP-1 and IL-2-promoter activities.
60. Peterson E.J., Clements J.L., Ballas Z.K., Koretzky G.A. NK cytokine secretion and cytotoxicity occur independently of the SLP-76 adaptor protein. Eur J Immunol. 29:1999;2223-2232.
61. -/- mice fail to demonstrate PLCγ1 phosphorylation, calcium mobilization and release of β-hexosaminidase and IL-6 upon FcεRI engagement.
62. •], this study also describes the independent cloning and characterization of Gads/Grf40/GrpL as a novel Grb2 homologue. The authors isolated Gads from a mouse embryo expression library through its association with a biotinylated Shc phosphopeptide.
63. Welsh M., Mares J., Karlsson T., Lavergne C., Breant B., Claesson-Welsh L. Shb is a ubiquitously expressed Src homology 2 protein. Oncogene. 9:1994;19-27.
64. Welsh M., Songyang Z., Frantz J.D., Trub T., Reedquist K.A., Karlsson T., Miyazaki M., Cantley L.C., Band H., Shoelson S.E. Stimulation through the T cell receptor leads to interactions between SHB and several signaling proteins. Oncogene. 16:1998;891-901.
65. Lindholm C.K., Gylfe E., Zhang W., Samelson L.E., Welsh M. Requirement of the Src homology 2 domain protein Shb for T cell receptor-dependent activation of the interleukin-2 gene nuclear factor for activation of T cells element in Jurkat T cells. J Biol Chem. 274:1999;28050-28057.
66. Blake T.J., Shapiro M., Morse H.C. III, Langdon W.Y. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene. 6:1991;653-657.
67. Keane M.M., Rivero-Lezcano O.M., Mitchell J.A., Robbins K.C., Lipkowitz S. Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene. Oncogene. 10:1995;2367-2377.
68. Donovan J.A., Wange R.L., Langdon W.Y., Samelson L.E. The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J Biol Chem. 269:1994;22921-22924.
69. Elly C., Witte S., Zhang Z., Rosnet O., Lipkowitz S., Altman A., Liu Y.C. Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation. Oncogene. 18:1999;1147-1156.
70. Panchamoorthy G., Fukazawa T., Miyake S., Soltoff S., Reedquist K., Druker B., Shoelson S., Cantley L., Band H. p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem. 271:1996;3187-3194.
71. Cory G.O., Lovering R.C., Hinshelwood S., MacCarthy-Morrogh L., Levinsky R.J., Kinnon C. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J Exp Med. 182:1995;611-615.
72. Kim T.J., Kim Y.T., Pillai S. Association of activated phosphatidyl inositol 3-kinase with p120cbl in antigen receptor-ligated B cells. J Biol Chem. 270:1995;27504-27509.
73. Hartley D., Meisner H., Corvera S. Specific association of the beta isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl. J Biol Chem. 270:1995;18260-18263.
74. Ingham R.J., Krebs D.L., Barbazuk S.M., Turck C.W., Hirai H., Matsuda M., Gold M.R. B cell antigen receptor signaling induces the formation of complexes containing the Crk adapter proteins. J Biol Chem. 271:1996;32306-32314.
75. Reedquist K.A., Fukazawa T., Panchamoorthy G., Langdon W.Y., Shoelson S.E., Druker B.J., Band H. Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J Biol Chem. 271:1996;8435-8442.
76. Marengere L.E., Mirtsos C., Kozieradzki I., Veillette A., Mak T.W., Penninger J.M. Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells. J Immunol. 159:1997;70-76.
77. Bustelo X.R., Crespo P., Lopez-Barahona M., Gutkind J.S., Barbacid M. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav- mediated c-Jun N-terminal kinase activation. Oncogene. 15:1997;2511-2520.
78. Ota Y., Samelson L.E. The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase. Science. 276:1997;418-420.
79. van Leeuwen J.E., Paik P.K., Samelson L.E. The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells. Mol Cell Biol. 19:1999;6652-6664.
80. Kong G., Dalton M., Wardenburg J.B., Straus D., Kurosaki T., Chan A.C. Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function. Mol Cell Biol. 16:1996;5026-5035.
81. Murphy M.A., Schnall R.G., Venter D.J., Barnett L., Bertoncello I., Thien C.B., Langdon W.Y., Bowtell D.D. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol Cell Biol. 18:1998;4872-4882.
82. Thien C.B., Bowtell D.D., Langdon W.Y. Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT and SLP-76 in c-Cbl-deficient thymocytes. J Immunol. 162:1999;7133-7139.
83. Bachmaier K., Krawczyk C., Kozieradzki I., Kong Y., Takehiko S., Oliveira dos-Santos A., Mariathasan S., Bouchard D., Wakeham A., Itie A.et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adapter Cbl-b. Nature. 403:2000;211-216. In this study, Cbl-b-deficient mice were generated and found to harbor profound defects in B and T cell immune responses, characterized by autoantibody production and generalized lymphocytic infiltration into multiple tissues. T cells from these mice demonstrate hyperproliferation and hyperproduction of IL-2 in response to TCR stimulation that are independent of CD28 costimulation. This finding was correlated with enhanced TCR-induced Vav phosphorylation observed in Cbl-b-deficient T cells.
84. Joazeiro C.A., Wing S.S., Huang H., Leverson J.D., Hunter T., Liu Y.C. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science. 286:1999;309-312. This study shows direct in vitro evidence of a function for the variant SH2 and RING domains of c-Cbl as a ubiquitin-protein ligase. These authors show that the c-Cbl RING domain can bind and allosterically activate the ubiquitin-conjugating enzyme, Ubc4, and that the variant SH2 domain of c-Cbl can serve as a substrate recognition site for the phosphorylated PDGF-Rb (platelet-derived-growth-factor-receptor-b) thereby promoting the ubiquitination and subsequent degradation of the activated receptor. Oncogenic forms of c-Cbl, which contain RING domain mutations, were shown to be defective in their ability act as ubiquitin ligases.
85. ••].
86. ••].
87. ••].
88. ••] demonstrate a role for c-Cbl in the attenuation and desensitization of receptor-tyrosine-kinase-mediated responses by promoting receptor polyubiquitination. In vitro and in vivo cellular approaches were taken to demonstrate the requirement for the RING domain of c-Cbl in mediating receptor ubiquitination and its ability to bind the ubiquitin-conjugating enzyme, UbcH7. In addition, mutations of c-Cbl in its RING domain were shown to provide a dominant inhibitory effect; this gives a plausible explanation for the oncogenic effects of c-Cbl mutants, which lack a functional RING domain.
89. Lupher M.L.Jr, Rao N., Lill N.L., Andoniou C.E., Miyake S., Clark E.A., Druker B., Band H. Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323. J Biol Chem. 273:1998;35273-35281.
90. Tanaka S., Morishita T., Hashimoto Y., Hattori S., Nakamura S., Shibuya M., Matuoka K., Takenawa T., Kurata T., Nagashima K. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci USA. 91:1994;3443-3447.
91. Boussiotis V.A., Freeman G.J., Berezovskaya A., Barber D.L., Nadler L.M. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science. 278:1997;124-128.
92. Marie-Cardine A., Kirchgessner H., Bruyns E., Shevchenko A., Mann M., Autschbach F., Ratnofsky S., Meuer S., Schraven B. SHP2-interacting transmembrane adaptor protein (SIT), a novel disulfide-linked dimer regulating human T cell activation. J Exp Med. 189:1999;1181-1194.
93. Cocks B.G., Chang C.C., Carballido J.M., Yssel H., de Vries J.E., Aversa G. A novel receptor involved in T-cell activation. Nature. 376:1995;260-263.
94. Aversa G., Chang C.C., Carballido J.M., Cocks B.G., de Vries J.E. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J Immunol. 158:1997;4036-4044.
95. Punnonen J., Cocks B.G., Carballido J.M., Bennett B., Peterson D., Aversa G., de Vries J.E. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J Exp Med. 185:1997;993-1004.
96. Sayos J., Wu C., Morra M., Wang N., Zhang X., Allen D., van Schaik S., Notarangelo L., Geha R., Roncarolo M.G.et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395:1998;462-469. In this study, SAP is identified by the yeast two-hybrid method as a novel SLAM-associated adapter molecule. Furthermore, SAP was found to be encoded by the gene for X-linked lymphoproliferative disease (XLP) by characterization of three XLP patients who carry mutations in the SAP gene. A possible mechanism for SAP function was demonstrated by its ability to act as a natural inhibitor of SHP-2 binding to phosphorylated SLAM and its ability to augment SLAM costimulatory effects on IL-2 promoter activity in Jurkat T cells.